Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas
ClinicalTrials.gov study NCT06925464. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Chidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT06151106. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of CHOP + Campath for T-Cell, Null Cell, or Natural Killer (NK)-Cell Lymphoma
ClinicalTrials.gov study NCT00161590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeted T-cell Therapy in Solid Tumors
ClinicalTrials.gov study NCT04076137. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evolution of CMV Antiviral T-cell Immunity Over the Next Six Months Initiation of Treatment With Belatacept.
ClinicalTrials.gov study NCT05708534. IPD Sharing: NO. Countries: 1. Publications: 0.
CD3/CD28 Bead Activated T-Cells Following Chemo-Immunotherapy in Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01013441. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT00476554. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase I Clinical Trial of Autologous CD7-CAR T Cell Therapy for High-risk Acute T-cell Leukemia/lymphoma
ClinicalTrials.gov study NCT04840875. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Injection (CNCT19) in the Treatment of Cluster of Differentiation 19 (CD19) Positive Relapsed or Refractory B Cell Malignancies
ClinicalTrials.gov study NCT04011293. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-BCMA CAR T-Cell Therapy for R/R ITP
ClinicalTrials.gov study NCT05315778. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
CD8+ T-cell PET/CT Imaging in COVID-19 Patients
ClinicalTrials.gov study NCT04874818. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1/2a Study of CDK-003 in Patients With Cutaneous T-Cell Lymphoma (CTCL).
ClinicalTrials.gov study NCT05156229. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase Ib/II Trial of Cladribine/Ruxolitinib/Venetoclax in Patients With Relapsed/Refractory T-cell Prolymphocytic Leukemia
ClinicalTrials.gov study NCT07311746. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Assess the Safety, Tolerability, Efficacy, and Drug Levels of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)
ClinicalTrials.gov study NCT06035497. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA with High Risk T-Cell ALL & Lymphoma
ClinicalTrials.gov study NCT04972942. IPD Sharing: NO. Countries: 1. Publications: 0.
T-cell Depleted Bone Marrow and G-CSF Stimulated Peripheral Stem Cell Transplantation From Related Donors in Treating Patients With Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, or Aplas
ClinicalTrials.gov study NCT00002718. IPD Sharing: Not stated. Countries: 1. Publications: 0.
DCVax-L Vaccination With CD3/CD28 Costimulated Autologous T-Cells for Recurrent Ovarian or Primary Peritoneal Cancer
ClinicalTrials.gov study NCT00603460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sequential Belimumab and T-cell Based Therapy in SLE
ClinicalTrials.gov study NCT04447053. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Blood and Tissue Sample Collection Study of Patients Who Have Inflammatory Bowel Disease, Who Have Been Treated With Adalimumab and Who Developed Hepatosplenic T-Cell Lymphoma
ClinicalTrials.gov study NCT02087878. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT00431912. IPD Sharing: Not stated. Countries: 4. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.